| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, Reducing | 29 | 2020 | 485 | 9.380 |
Why?
|
| Weight Loss | 43 | 2020 | 2684 | 6.190 |
Why?
|
| Obesity | 103 | 2020 | 12947 | 5.390 |
Why?
|
| Polymorphism, Single Nucleotide | 126 | 2020 | 15936 | 4.390 |
Why?
|
| Overweight | 32 | 2020 | 2417 | 4.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 92 | 2019 | 12148 | 3.910 |
Why?
|
| Genetic Predisposition to Disease | 108 | 2020 | 17904 | 3.810 |
Why?
|
| Genotype | 75 | 2020 | 12990 | 3.750 |
Why?
|
| Diet | 42 | 2020 | 8075 | 3.480 |
Why?
|
| Receptor, Melatonin, MT2 | 7 | 2020 | 82 | 3.230 |
Why?
|
| Diet, Fat-Restricted | 13 | 2019 | 329 | 3.230 |
Why?
|
| Insulin Resistance | 34 | 2019 | 3963 | 3.200 |
Why?
|
| Adiposity | 28 | 2020 | 1879 | 3.200 |
Why?
|
| Body Mass Index | 93 | 2020 | 12954 | 3.060 |
Why?
|
| Diabetes, Gestational | 15 | 2020 | 1248 | 2.650 |
Why?
|
| Dietary Proteins | 14 | 2019 | 952 | 2.430 |
Why?
|
| Blood Glucose | 33 | 2019 | 6391 | 2.290 |
Why?
|
| Genetic Variation | 38 | 2019 | 6567 | 2.260 |
Why?
|
| Weight Gain | 17 | 2019 | 2348 | 2.250 |
Why?
|
| Cardiovascular Diseases | 38 | 2020 | 15501 | 2.180 |
Why?
|
| Adiponectin | 15 | 2017 | 1113 | 2.120 |
Why?
|
| Receptor, Melanocortin, Type 4 | 5 | 2019 | 129 | 2.100 |
Why?
|
| Life Style | 25 | 2020 | 3917 | 2.100 |
Why?
|
| China | 54 | 2019 | 2374 | 1.880 |
Why?
|
| Dietary Fats | 19 | 2019 | 1995 | 1.870 |
Why?
|
| Genome-Wide Association Study | 76 | 2019 | 12690 | 1.640 |
Why?
|
| Body Composition | 8 | 2019 | 2426 | 1.610 |
Why?
|
| Waist Circumference | 15 | 2020 | 935 | 1.600 |
Why?
|
| Methylamines | 5 | 2019 | 136 | 1.560 |
Why?
|
| Dietary Fiber | 10 | 2015 | 759 | 1.530 |
Why?
|
| Middle Aged | 207 | 2020 | 220920 | 1.520 |
Why?
|
| Energy Intake | 16 | 2020 | 2134 | 1.500 |
Why?
|
| Adult | 201 | 2020 | 221203 | 1.450 |
Why?
|
| Body Weight | 17 | 2019 | 4618 | 1.430 |
Why?
|
| Diabetic Angiopathies | 9 | 2019 | 803 | 1.420 |
Why?
|
| Caloric Restriction | 6 | 2020 | 299 | 1.410 |
Why?
|
| Obesity, Abdominal | 7 | 2019 | 374 | 1.370 |
Why?
|
| Sewage | 8 | 2017 | 42 | 1.370 |
Why?
|
| Female | 267 | 2020 | 392686 | 1.360 |
Why?
|
| Appetite | 3 | 2017 | 247 | 1.360 |
Why?
|
| Insulin | 22 | 2019 | 6597 | 1.330 |
Why?
|
| Feeding Behavior | 17 | 2020 | 3188 | 1.290 |
Why?
|
| Neuropeptide Y | 3 | 2015 | 192 | 1.210 |
Why?
|
| Birth Weight | 7 | 2019 | 2103 | 1.200 |
Why?
|
| Gallstones | 4 | 2018 | 284 | 1.180 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2019 | 1007 | 1.150 |
Why?
|
| Proteins | 14 | 2017 | 6032 | 1.140 |
Why?
|
| Male | 215 | 2020 | 360842 | 1.140 |
Why?
|
| Prehypertension | 4 | 2015 | 63 | 1.140 |
Why?
|
| Risk Factors | 100 | 2020 | 74213 | 1.120 |
Why?
|
| Hypertension | 20 | 2019 | 8540 | 1.100 |
Why?
|
| Beverages | 6 | 2017 | 821 | 1.090 |
Why?
|
| Humans | 326 | 2020 | 761572 | 1.080 |
Why?
|
| Vitamin D | 7 | 2019 | 3303 | 1.070 |
Why?
|
| Alleles | 32 | 2019 | 6864 | 1.060 |
Why?
|
| Amino Acids, Branched-Chain | 5 | 2018 | 269 | 1.060 |
Why?
|
| Phosphatidylcholines | 3 | 2019 | 405 | 1.050 |
Why?
|
| Carnitine | 5 | 2019 | 252 | 1.010 |
Why?
|
| Neck | 3 | 2015 | 734 | 0.990 |
Why?
|
| Waist-Hip Ratio | 19 | 2019 | 518 | 0.990 |
Why?
|
| Coronary Disease | 11 | 2019 | 5914 | 0.980 |
Why?
|
| Dietary Carbohydrates | 12 | 2018 | 891 | 0.960 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2019 | 1390 | 0.960 |
Why?
|
| Body Height | 7 | 2017 | 1570 | 0.940 |
Why?
|
| Vitamin B Complex | 2 | 2018 | 299 | 0.940 |
Why?
|
| tRNA Methyltransferases | 3 | 2019 | 52 | 0.930 |
Why?
|
| Prospective Studies | 59 | 2020 | 54426 | 0.910 |
Why?
|
| Cholesterol, HDL | 6 | 2015 | 1814 | 0.900 |
Why?
|
| Coffee | 3 | 2017 | 593 | 0.880 |
Why?
|
| Aged | 112 | 2020 | 169310 | 0.870 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2019 | 557 | 0.850 |
Why?
|
| Bone Density | 4 | 2019 | 3551 | 0.850 |
Why?
|
| Amino Acids | 3 | 2019 | 1718 | 0.840 |
Why?
|
| Genetic Loci | 20 | 2018 | 2632 | 0.820 |
Why?
|
| Waste Disposal, Fluid | 3 | 2016 | 33 | 0.800 |
Why?
|
| Glycemic Index | 5 | 2009 | 396 | 0.790 |
Why?
|
| Choline | 3 | 2019 | 515 | 0.790 |
Why?
|
| Triglycerides | 5 | 2015 | 2461 | 0.790 |
Why?
|
| Body Fat Distribution | 6 | 2019 | 245 | 0.760 |
Why?
|
| Exercise | 15 | 2019 | 5890 | 0.760 |
Why?
|
| Postpartum Period | 7 | 2019 | 1173 | 0.750 |
Why?
|
| Follow-Up Studies | 35 | 2020 | 39107 | 0.740 |
Why?
|
| Dietary Sucrose | 3 | 2013 | 243 | 0.740 |
Why?
|
| Glutamic Acid | 4 | 2018 | 1176 | 0.740 |
Why?
|
| Lactase | 2 | 2018 | 71 | 0.730 |
Why?
|
| ABO Blood-Group System | 4 | 2013 | 380 | 0.730 |
Why?
|
| Gene Frequency | 17 | 2019 | 3606 | 0.720 |
Why?
|
| Nutrigenomics | 2 | 2017 | 24 | 0.720 |
Why?
|
| Fasting | 11 | 2018 | 1603 | 0.720 |
Why?
|
| Odds Ratio | 24 | 2019 | 9646 | 0.710 |
Why?
|
| Salivary alpha-Amylases | 1 | 2020 | 15 | 0.710 |
Why?
|
| Diabetes Complications | 3 | 2019 | 1315 | 0.700 |
Why?
|
| Abdominal Fat | 2 | 2015 | 221 | 0.700 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2014 | 363 | 0.690 |
Why?
|
| Linkage Disequilibrium | 10 | 2012 | 1998 | 0.690 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2018 | 131 | 0.690 |
Why?
|
| Apolipoproteins A | 2 | 2012 | 95 | 0.660 |
Why?
|
| Uric Acid | 5 | 2019 | 807 | 0.660 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 100 | 0.650 |
Why?
|
| Glucosamine | 1 | 2019 | 128 | 0.640 |
Why?
|
| Fishes | 2 | 2019 | 603 | 0.640 |
Why?
|
| Blood Pressure | 14 | 2019 | 8481 | 0.640 |
Why?
|
| Dietary Supplements | 4 | 2019 | 3415 | 0.640 |
Why?
|
| Receptors, Interleukin-6 | 3 | 2012 | 225 | 0.630 |
Why?
|
| Iron | 5 | 2014 | 1793 | 0.630 |
Why?
|
| Linear Models | 16 | 2019 | 5872 | 0.620 |
Why?
|
| Risk Assessment | 24 | 2019 | 23996 | 0.620 |
Why?
|
| Vegetables | 3 | 2019 | 1195 | 0.610 |
Why?
|
| Nitrogen | 3 | 2017 | 348 | 0.610 |
Why?
|
| Case-Control Studies | 39 | 2019 | 22176 | 0.600 |
Why?
|
| Biological Specimen Banks | 3 | 2020 | 783 | 0.600 |
Why?
|
| Glucose Tolerance Test | 8 | 2018 | 1178 | 0.590 |
Why?
|
| Pancreatic alpha-Amylases | 1 | 2017 | 7 | 0.590 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2018 | 174 | 0.580 |
Why?
|
| Glutamine | 2 | 2018 | 577 | 0.570 |
Why?
|
| Fibroblast Growth Factors | 5 | 2018 | 867 | 0.570 |
Why?
|
| Sweetening Agents | 2 | 2017 | 290 | 0.560 |
Why?
|
| Amino Acids, Aromatic | 2 | 2016 | 36 | 0.560 |
Why?
|
| Nurses | 11 | 2019 | 2478 | 0.550 |
Why?
|
| Cation Transport Proteins | 2 | 2016 | 327 | 0.550 |
Why?
|
| Cryptochromes | 2 | 2013 | 48 | 0.550 |
Why?
|
| Dyslipidemias | 5 | 2018 | 868 | 0.540 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 5 | 2012 | 152 | 0.540 |
Why?
|
| Asymptomatic Diseases | 3 | 2019 | 588 | 0.540 |
Why?
|
| Genetic Association Studies | 11 | 2019 | 2735 | 0.540 |
Why?
|
| Fruit | 2 | 2019 | 1160 | 0.540 |
Why?
|
| Diabetes Mellitus | 9 | 2019 | 5841 | 0.530 |
Why?
|
| Insulin-Secreting Cells | 4 | 2019 | 901 | 0.530 |
Why?
|
| Taurine | 1 | 2016 | 93 | 0.520 |
Why?
|
| Myocardial Infarction | 6 | 2017 | 11461 | 0.520 |
Why?
|
| Methane | 1 | 2016 | 52 | 0.520 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2014 | 113 | 0.520 |
Why?
|
| Quantitative Trait Loci | 13 | 2017 | 2116 | 0.520 |
Why?
|
| Longitudinal Studies | 23 | 2019 | 14607 | 0.520 |
Why?
|
| DNA Methylation | 4 | 2018 | 4399 | 0.510 |
Why?
|
| Environment | 3 | 2019 | 1123 | 0.510 |
Why?
|
| Haplotypes | 8 | 2015 | 2713 | 0.500 |
Why?
|
| Cohort Studies | 42 | 2019 | 41493 | 0.500 |
Why?
|
| Costa Rica | 5 | 2017 | 180 | 0.490 |
Why?
|
| E-Selectin | 4 | 2011 | 576 | 0.490 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2012 | 39 | 0.490 |
Why?
|
| Phosphoproteins | 5 | 2008 | 2448 | 0.480 |
Why?
|
| United States | 40 | 2019 | 72335 | 0.480 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 112 | 0.480 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 359 | 0.480 |
Why?
|
| Subtilisins | 1 | 2014 | 81 | 0.480 |
Why?
|
| Body Image | 1 | 2019 | 638 | 0.470 |
Why?
|
| Resistin | 2 | 2012 | 172 | 0.470 |
Why?
|
| Circadian Rhythm | 2 | 2018 | 2576 | 0.470 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 526 | 0.470 |
Why?
|
| Vitamin D Deficiency | 3 | 2019 | 1388 | 0.460 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 1112 | 0.460 |
Why?
|
| Smoking | 9 | 2019 | 9053 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2016 | 535 | 0.460 |
Why?
|
| Health | 1 | 2017 | 398 | 0.460 |
Why?
|
| Lipids | 8 | 2020 | 3341 | 0.460 |
Why?
|
| Interleukin-6 | 4 | 2008 | 3208 | 0.460 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2013 | 31 | 0.450 |
Why?
|
| Infant, Low Birth Weight | 2 | 2016 | 870 | 0.450 |
Why?
|
| Risk | 14 | 2018 | 9610 | 0.450 |
Why?
|
| Pruritus | 1 | 2017 | 380 | 0.440 |
Why?
|
| Drug Utilization | 1 | 2019 | 1188 | 0.440 |
Why?
|
| Self Concept | 1 | 2019 | 1045 | 0.440 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2013 | 75 | 0.440 |
Why?
|
| Hematocrit | 1 | 2015 | 623 | 0.440 |
Why?
|
| Genetic Determinism | 1 | 2013 | 10 | 0.440 |
Why?
|
| Pregnancy | 24 | 2020 | 29876 | 0.430 |
Why?
|
| zeta-Crystallins | 1 | 2012 | 4 | 0.420 |
Why?
|
| Motor Activity | 6 | 2016 | 2715 | 0.420 |
Why?
|
| Lipase | 1 | 2015 | 325 | 0.420 |
Why?
|
| Starvation | 4 | 2018 | 142 | 0.410 |
Why?
|
| Maternal Exposure | 1 | 2019 | 1067 | 0.410 |
Why?
|
| Eating | 2 | 2010 | 1539 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7407 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 6 | 2018 | 789 | 0.410 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 513 | 0.400 |
Why?
|
| Zinc | 1 | 2016 | 690 | 0.400 |
Why?
|
| Incidence | 20 | 2020 | 21355 | 0.400 |
Why?
|
| Glucose | 4 | 2018 | 4346 | 0.390 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 3 | 2016 | 8 | 0.390 |
Why?
|
| Genetic Markers | 5 | 2019 | 2601 | 0.390 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2017 | 851 | 0.390 |
Why?
|
| Cooking | 1 | 2014 | 315 | 0.390 |
Why?
|
| Carrier Proteins | 7 | 2018 | 4937 | 0.390 |
Why?
|
| Sulfotransferases | 1 | 2012 | 150 | 0.390 |
Why?
|
| Constipation | 1 | 2016 | 563 | 0.390 |
Why?
|
| MicroRNAs | 8 | 2017 | 3816 | 0.380 |
Why?
|
| Metabolic Diseases | 2 | 2016 | 683 | 0.370 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 376 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 638 | 0.370 |
Why?
|
| Health Surveys | 11 | 2016 | 4061 | 0.370 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 1902 | 0.370 |
Why?
|
| Multivariate Analysis | 13 | 2017 | 12059 | 0.370 |
Why?
|
| Mortality | 2 | 2019 | 2901 | 0.360 |
Why?
|
| Leisure Activities | 1 | 2012 | 308 | 0.360 |
Why?
|
| Parathyroid Hormone | 1 | 2017 | 1803 | 0.360 |
Why?
|
| Asthma | 3 | 2019 | 6234 | 0.360 |
Why?
|
| Dairy Products | 3 | 2019 | 490 | 0.360 |
Why?
|
| Health Behavior | 3 | 2017 | 2644 | 0.350 |
Why?
|
| Heme | 3 | 2012 | 313 | 0.350 |
Why?
|
| C-Reactive Protein | 6 | 2018 | 3826 | 0.350 |
Why?
|
| Louisiana | 5 | 2019 | 103 | 0.350 |
Why?
|
| Time Factors | 17 | 2019 | 39970 | 0.340 |
Why?
|
| Nervous System | 1 | 2013 | 545 | 0.340 |
Why?
|
| Atherosclerosis | 4 | 2014 | 3408 | 0.340 |
Why?
|
| Television | 1 | 2012 | 408 | 0.330 |
Why?
|
| Diarrhea | 1 | 2016 | 1318 | 0.330 |
Why?
|
| Young Adult | 33 | 2019 | 59255 | 0.330 |
Why?
|
| Polymorphism, Genetic | 7 | 2009 | 4243 | 0.330 |
Why?
|
| Fluorocarbons | 3 | 2020 | 492 | 0.330 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3877 | 0.330 |
Why?
|
| Cross-Sectional Studies | 22 | 2019 | 26127 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.320 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1136 | 0.320 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 22 | 0.320 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5485 | 0.320 |
Why?
|
| Body Patterning | 1 | 2013 | 632 | 0.320 |
Why?
|
| Neoplasms | 7 | 2019 | 22173 | 0.310 |
Why?
|
| Women's Health | 4 | 2016 | 2065 | 0.310 |
Why?
|
| Interleukin-18 | 1 | 2010 | 250 | 0.300 |
Why?
|
| Cholesterol, LDL | 2 | 2015 | 2382 | 0.300 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.300 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 1651 | 0.300 |
Why?
|
| Hyperglycemia | 5 | 2017 | 1376 | 0.290 |
Why?
|
| Membrane Proteins | 7 | 2018 | 7858 | 0.290 |
Why?
|
| Nutrition Surveys | 4 | 2019 | 1733 | 0.290 |
Why?
|
| Fatty Liver | 1 | 2014 | 790 | 0.290 |
Why?
|
| Alcohol Drinking | 7 | 2019 | 4028 | 0.290 |
Why?
|
| Anthropometry | 5 | 2016 | 1349 | 0.290 |
Why?
|
| Desiccation | 3 | 2017 | 78 | 0.290 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 771 | 0.290 |
Why?
|
| Energy Metabolism | 3 | 2018 | 2882 | 0.290 |
Why?
|
| Aging | 6 | 2018 | 8711 | 0.280 |
Why?
|
| Temperature | 4 | 2018 | 2226 | 0.280 |
Why?
|
| Sex Characteristics | 7 | 2019 | 2639 | 0.280 |
Why?
|
| Age Factors | 16 | 2019 | 18398 | 0.280 |
Why?
|
| Epidemiology | 1 | 2009 | 279 | 0.280 |
Why?
|
| Adipose Tissue | 8 | 2019 | 3312 | 0.280 |
Why?
|
| Lipoprotein(a) | 1 | 2011 | 480 | 0.270 |
Why?
|
| Absorptiometry, Photon | 3 | 2019 | 1738 | 0.270 |
Why?
|
| Adolescent | 33 | 2019 | 88324 | 0.270 |
Why?
|
| Diet, Protein-Restricted | 2 | 2018 | 73 | 0.270 |
Why?
|
| Meat | 3 | 2015 | 584 | 0.270 |
Why?
|
| Gene Expression Regulation | 11 | 2019 | 11904 | 0.260 |
Why?
|
| Diabetic Retinopathy | 3 | 2019 | 1274 | 0.260 |
Why?
|
| Nutritional Status | 3 | 2019 | 1615 | 0.250 |
Why?
|
| Proportional Hazards Models | 9 | 2019 | 12463 | 0.250 |
Why?
|
| Influenza in Birds | 2 | 2016 | 76 | 0.250 |
Why?
|
| Seafood | 2 | 2019 | 393 | 0.250 |
Why?
|
| Heterozygote | 6 | 2017 | 2787 | 0.250 |
Why?
|
| DNA-Binding Proteins | 5 | 2017 | 9610 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3612 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5790 | 0.240 |
Why?
|
| Inflammation Mediators | 3 | 2012 | 1886 | 0.240 |
Why?
|
| Basal Metabolism | 2 | 2018 | 161 | 0.240 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 299 | 0.240 |
Why?
|
| Apolipoprotein C-III | 1 | 2006 | 211 | 0.240 |
Why?
|
| Sex Factors | 10 | 2019 | 10553 | 0.240 |
Why?
|
| Cause of Death | 4 | 2019 | 3683 | 0.240 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 3847 | 0.230 |
Why?
|
| Prognosis | 13 | 2020 | 29629 | 0.230 |
Why?
|
| Body Size | 3 | 2016 | 463 | 0.230 |
Why?
|
| Residence Characteristics | 1 | 2014 | 2094 | 0.230 |
Why?
|
| Health Personnel | 7 | 2018 | 3335 | 0.230 |
Why?
|
| TCF Transcription Factors | 3 | 2010 | 138 | 0.230 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2015 | 113 | 0.230 |
Why?
|
| Health Status | 1 | 2017 | 4077 | 0.230 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2012 | 1349 | 0.230 |
Why?
|
| Pain | 1 | 2019 | 5073 | 0.230 |
Why?
|
| Plant Extracts | 2 | 2019 | 498 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 344 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2016 | 457 | 0.220 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2015 | 227 | 0.220 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 264 | 0.220 |
Why?
|
| Logistic Models | 11 | 2018 | 13255 | 0.220 |
Why?
|
| Aged, 80 and over | 21 | 2018 | 58986 | 0.220 |
Why?
|
| Environmental Pollutants | 3 | 2019 | 1277 | 0.210 |
Why?
|
| Nitrification | 3 | 2017 | 5 | 0.210 |
Why?
|
| Receptors, Cell Surface | 3 | 2013 | 2822 | 0.210 |
Why?
|
| Abortion, Habitual | 2 | 2014 | 61 | 0.210 |
Why?
|
| Metabolome | 3 | 2019 | 989 | 0.210 |
Why?
|
| Treatment Outcome | 10 | 2020 | 64684 | 0.200 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2015 | 569 | 0.200 |
Why?
|
| Homeostasis | 4 | 2014 | 3323 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2013 | 329 | 0.190 |
Why?
|
| Diet Surveys | 2 | 2015 | 1162 | 0.190 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2001 | 89 | 0.190 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2015 | 445 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2015 | 2986 | 0.180 |
Why?
|
| Animals | 26 | 2019 | 168467 | 0.180 |
Why?
|
| Blood Pressure Determination | 3 | 2019 | 633 | 0.180 |
Why?
|
| Colorectal Neoplasms | 6 | 2017 | 6935 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2017 | 12129 | 0.180 |
Why?
|
| ras Proteins | 2 | 2017 | 1054 | 0.180 |
Why?
|
| Docosahexaenoic Acids | 2 | 2017 | 908 | 0.180 |
Why?
|
| Vitamins | 2 | 2019 | 1635 | 0.180 |
Why?
|
| Flocculation | 2 | 2016 | 3 | 0.180 |
Why?
|
| Albuminuria | 2 | 2016 | 657 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2019 | 2518 | 0.170 |
Why?
|
| Phenols | 2 | 2015 | 517 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 10 | 2019 | 1380 | 0.170 |
Why?
|
| Epigenesis, Genetic | 5 | 2017 | 3801 | 0.170 |
Why?
|
| Inflammation | 6 | 2018 | 10773 | 0.170 |
Why?
|
| Iron, Dietary | 2 | 2011 | 148 | 0.170 |
Why?
|
| Zeolites | 2 | 2017 | 9 | 0.170 |
Why?
|
| Heart | 1 | 2012 | 4404 | 0.170 |
Why?
|
| Phobic Disorders | 2 | 2013 | 439 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 105 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 3 | 2016 | 2177 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2018 | 10212 | 0.160 |
Why?
|
| Metabolomics | 3 | 2019 | 1659 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2016 | 543 | 0.160 |
Why?
|
| Glycoproteins | 2 | 2018 | 2203 | 0.160 |
Why?
|
| Propionates | 1 | 2019 | 183 | 0.150 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2019 | 76 | 0.150 |
Why?
|
| Primulaceae | 1 | 2017 | 2 | 0.150 |
Why?
|
| Prevalence | 8 | 2018 | 15732 | 0.150 |
Why?
|
| Chromosome Mapping | 4 | 2015 | 4615 | 0.150 |
Why?
|
| Genome, Human | 8 | 2015 | 4425 | 0.150 |
Why?
|
| Patient Compliance | 3 | 2017 | 2690 | 0.150 |
Why?
|
| Metamorphosis, Biological | 1 | 2017 | 37 | 0.150 |
Why?
|
| Transportation | 1 | 2019 | 217 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 135 | 0.150 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2017 | 37 | 0.150 |
Why?
|
| Bifidobacterium | 1 | 2018 | 97 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 174 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4352 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.140 |
Why?
|
| Postprandial Period | 1 | 2019 | 315 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.140 |
Why?
|
| Biological Clocks | 1 | 2019 | 318 | 0.140 |
Why?
|
| Cohort Effect | 1 | 2016 | 39 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2456 | 0.140 |
Why?
|
| Glucagon | 1 | 2019 | 532 | 0.140 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2018 | 262 | 0.140 |
Why?
|
| Glycopeptides | 1 | 2018 | 220 | 0.140 |
Why?
|
| Systole | 1 | 2019 | 936 | 0.140 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2014 | 102 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2019 | 26198 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2019 | 338 | 0.140 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 352 | 0.140 |
Why?
|
| Stroke | 3 | 2019 | 9758 | 0.140 |
Why?
|
| Diastole | 1 | 2019 | 782 | 0.130 |
Why?
|
| Water Purification | 1 | 2016 | 60 | 0.130 |
Why?
|
| Hydrazines | 1 | 2018 | 224 | 0.130 |
Why?
|
| Behavior | 1 | 2019 | 541 | 0.130 |
Why?
|
| Adipokines | 2 | 2009 | 310 | 0.130 |
Why?
|
| Phenotype | 11 | 2019 | 16592 | 0.130 |
Why?
|
| Sleep | 3 | 2020 | 4768 | 0.130 |
Why?
|
| Ligustrum | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hydrodynamics | 1 | 2017 | 168 | 0.130 |
Why?
|
| Mice | 16 | 2019 | 81533 | 0.130 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2015 | 33 | 0.130 |
Why?
|
| Spices | 1 | 2015 | 11 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 421 | 0.130 |
Why?
|
| Principal Component Analysis | 2 | 2016 | 945 | 0.130 |
Why?
|
| Hyperinsulinism | 2 | 2016 | 400 | 0.120 |
Why?
|
| Biota | 1 | 2015 | 23 | 0.120 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 1035 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2011 | 1126 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 2898 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13382 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 318 | 0.120 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 315 | 0.120 |
Why?
|
| Reference Values | 3 | 2007 | 4920 | 0.120 |
Why?
|
| Ammonia | 1 | 2016 | 237 | 0.120 |
Why?
|
| Oxygen | 2 | 2016 | 4227 | 0.120 |
Why?
|
| Riboflavin | 1 | 2015 | 107 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 365 | 0.120 |
Why?
|
| Cold Temperature | 2 | 2016 | 785 | 0.120 |
Why?
|
| Child | 16 | 2020 | 80156 | 0.120 |
Why?
|
| American Heart Association | 1 | 2019 | 1039 | 0.120 |
Why?
|
| Fabaceae | 1 | 2015 | 103 | 0.120 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4486 | 0.120 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.120 |
Why?
|
| Sex Distribution | 3 | 2015 | 2281 | 0.120 |
Why?
|
| Allium | 1 | 2014 | 7 | 0.120 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2014 | 48 | 0.120 |
Why?
|
| Bacteria | 2 | 2015 | 2199 | 0.120 |
Why?
|
| Heterocyclic Compounds | 1 | 2015 | 246 | 0.120 |
Why?
|
| Arterioles | 1 | 2015 | 250 | 0.120 |
Why?
|
| Garlic | 1 | 2014 | 28 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2018 | 9319 | 0.120 |
Why?
|
| Organic Chemicals | 1 | 2015 | 210 | 0.120 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 121 | 0.110 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 144 | 0.110 |
Why?
|
| Child, Preschool | 10 | 2020 | 42230 | 0.110 |
Why?
|
| Vitamin B 6 | 1 | 2015 | 234 | 0.110 |
Why?
|
| Age Distribution | 3 | 2015 | 2880 | 0.110 |
Why?
|
| Signal Transduction | 7 | 2019 | 23447 | 0.110 |
Why?
|
| Survival Rate | 2 | 2019 | 12725 | 0.110 |
Why?
|
| Amines | 1 | 2015 | 281 | 0.110 |
Why?
|
| Influenza, Human | 2 | 2015 | 1521 | 0.110 |
Why?
|
| Lysophospholipase | 2 | 2014 | 66 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 561 | 0.110 |
Why?
|
| Polymers | 2 | 2018 | 1617 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1001 | 0.110 |
Why?
|
| Cardiac Myosins | 1 | 2014 | 128 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.110 |
Why?
|
| Comorbidity | 3 | 2018 | 10508 | 0.110 |
Why?
|
| Fast Foods | 1 | 2015 | 211 | 0.110 |
Why?
|
| Metals | 1 | 2018 | 719 | 0.110 |
Why?
|
| Exosomes | 1 | 2018 | 424 | 0.110 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 107 | 0.110 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2012 | 5 | 0.110 |
Why?
|
| Aerosols | 1 | 2015 | 635 | 0.110 |
Why?
|
| 5'-Nucleotidase | 1 | 2014 | 161 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4513 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 208 | 0.100 |
Why?
|
| Cysteine | 1 | 1997 | 891 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 364 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 1171 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1787 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 1336 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 227 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21017 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1479 | 0.100 |
Why?
|
| Walking | 1 | 2019 | 1198 | 0.100 |
Why?
|
| Femur | 1 | 2018 | 1307 | 0.100 |
Why?
|
| Mongolia | 1 | 2012 | 93 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 524 | 0.100 |
Why?
|
| Epigenomics | 2 | 2017 | 943 | 0.100 |
Why?
|
| Mitochondrial Proteins | 2 | 2009 | 976 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 2 | 2015 | 613 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2011 | 2186 | 0.100 |
Why?
|
| Europe | 5 | 2017 | 3422 | 0.100 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 177 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2015 | 513 | 0.100 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2014 | 550 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2017 | 2490 | 0.090 |
Why?
|
| Graves Disease | 1 | 2013 | 238 | 0.090 |
Why?
|
| Genomics | 5 | 2018 | 5821 | 0.090 |
Why?
|
| Benzhydryl Compounds | 2 | 2015 | 916 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2019 | 80646 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 877 | 0.090 |
Why?
|
| Transferrin | 1 | 2012 | 283 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2019 | 1063 | 0.090 |
Why?
|
| Boston | 2 | 2016 | 9326 | 0.090 |
Why?
|
| Age of Onset | 1 | 2018 | 3306 | 0.090 |
Why?
|
| Heart Rate | 2 | 2013 | 4195 | 0.090 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2010 | 33 | 0.090 |
Why?
|
| Gestational Age | 2 | 2016 | 3577 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 408 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2015 | 868 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2201 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 8601 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2707 | 0.090 |
Why?
|
| Cholesterol | 1 | 2019 | 2904 | 0.090 |
Why?
|
| Virus Replication | 2 | 2015 | 2435 | 0.090 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 518 | 0.090 |
Why?
|
| Macrophages | 2 | 2019 | 5769 | 0.090 |
Why?
|
| Osteocalcin | 1 | 2010 | 274 | 0.090 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.090 |
Why?
|
| Diet, Mediterranean | 2 | 2018 | 740 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6534 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2017 | 1199 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.080 |
Why?
|
| Computational Biology | 2 | 2019 | 3517 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 459 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1062 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1246 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1186 | 0.080 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 455 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 80 | 0.080 |
Why?
|
| 3' Untranslated Regions | 3 | 2017 | 519 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 764 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 585 | 0.080 |
Why?
|
| P-Selectin | 1 | 2011 | 597 | 0.080 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 293 | 0.080 |
Why?
|
| Heredity | 1 | 2009 | 148 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 768 | 0.080 |
Why?
|
| Blood Proteins | 1 | 2014 | 1173 | 0.080 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 454 | 0.080 |
Why?
|
| Epidemiologic Studies | 3 | 2016 | 675 | 0.080 |
Why?
|
| Angiotensinogen | 1 | 2009 | 161 | 0.080 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2010 | 160 | 0.080 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2009 | 158 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2016 | 2919 | 0.080 |
Why?
|
| Malaysia | 2 | 2006 | 107 | 0.080 |
Why?
|
| ROC Curve | 2 | 2014 | 3579 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 350 | 0.080 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 153 | 0.080 |
Why?
|
| Folic Acid | 1 | 2015 | 1323 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2017 | 8552 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2421 | 0.070 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 728 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2016 | 3575 | 0.070 |
Why?
|
| Singapore | 2 | 2006 | 292 | 0.070 |
Why?
|
| Social Class | 1 | 2016 | 2004 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 698 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15843 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2015 | 1804 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2865 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22172 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1674 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1406 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 551 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2026 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.070 |
Why?
|
| Receptors, Adiponectin | 1 | 2007 | 81 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 413 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1616 | 0.070 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 9420 | 0.070 |
Why?
|
| Potassium Channels | 1 | 2009 | 537 | 0.070 |
Why?
|
| Publication Bias | 2 | 2019 | 160 | 0.070 |
Why?
|
| Intestines | 1 | 2015 | 1909 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2016 | 3442 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2018 | 2176 | 0.070 |
Why?
|
| Adipocytes | 2 | 2015 | 1194 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 858 | 0.070 |
Why?
|
| Cadherins | 1 | 2011 | 903 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3701 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 4431 | 0.060 |
Why?
|
| Developed Countries | 1 | 2009 | 449 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3810 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16986 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1277 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7827 | 0.060 |
Why?
|
| Fetus | 1 | 2013 | 1863 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2922 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2449 | 0.060 |
Why?
|
| Iran | 2 | 2019 | 737 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 6815 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2018 | 2781 | 0.060 |
Why?
|
| DNA | 2 | 2012 | 7213 | 0.060 |
Why?
|
| Massachusetts | 1 | 2018 | 8830 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2013 | 4001 | 0.060 |
Why?
|
| Telomere | 1 | 2011 | 943 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2013 | 1808 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18253 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 2113 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 4989 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9541 | 0.060 |
Why?
|
| Renin-Angiotensin System | 1 | 2009 | 737 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2872 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2007 | 222 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 13510 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10448 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2017 | 2190 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2008 | 743 | 0.060 |
Why?
|
| Chickens | 2 | 2016 | 859 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14666 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2015 | 6214 | 0.050 |
Why?
|
| HCT116 Cells | 2 | 2014 | 404 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2244 | 0.050 |
Why?
|
| Binding Sites | 3 | 2015 | 6056 | 0.050 |
Why?
|
| Mental Health | 1 | 2017 | 3250 | 0.050 |
Why?
|
| Gene Expression | 2 | 2012 | 7581 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4280 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 20099 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 368 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4434 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15266 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6228 | 0.050 |
Why?
|
| Mutation | 2 | 2018 | 30054 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3449 | 0.050 |
Why?
|
| India | 2 | 2006 | 2348 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2015 | 2896 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6992 | 0.050 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.050 |
Why?
|
| Genetics, Population | 3 | 2014 | 937 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1336 | 0.050 |
Why?
|
| Kidney | 1 | 2016 | 7047 | 0.050 |
Why?
|
| Ion Channels | 1 | 2006 | 1040 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1897 | 0.050 |
Why?
|
| Virulence | 2 | 2015 | 1303 | 0.050 |
Why?
|
| Schizophrenia | 2 | 2018 | 6937 | 0.040 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 2000 | 56 | 0.040 |
Why?
|
| Asia | 2 | 2016 | 619 | 0.040 |
Why?
|
| Anemia | 1 | 2009 | 1509 | 0.040 |
Why?
|
| Decanoic Acids | 1 | 2020 | 68 | 0.040 |
Why?
|
| Sulfonic Acids | 1 | 2020 | 103 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2002 | 584 | 0.040 |
Why?
|
| COS Cells | 2 | 2001 | 1130 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2341 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2015 | 2927 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2017 | 3614 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6403 | 0.040 |
Why?
|
| Plants, Edible | 1 | 2019 | 30 | 0.040 |
Why?
|
| Causality | 2 | 2018 | 1242 | 0.040 |
Why?
|
| Infant | 4 | 2017 | 36192 | 0.040 |
Why?
|
| Caprylates | 1 | 2020 | 115 | 0.040 |
Why?
|
| Yogurt | 1 | 2019 | 71 | 0.040 |
Why?
|
| Satiation | 1 | 2019 | 83 | 0.040 |
Why?
|
| Aquatic Organisms | 1 | 2019 | 42 | 0.040 |
Why?
|
| Depression | 1 | 2018 | 8124 | 0.040 |
Why?
|
| Genetic Heterogeneity | 2 | 2014 | 732 | 0.040 |
Why?
|
| Glycogen | 1 | 2019 | 251 | 0.040 |
Why?
|
| Cytokines | 2 | 2015 | 7396 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 5799 | 0.040 |
Why?
|
| Antimony | 1 | 2018 | 20 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2009 | 2091 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 2018 | 77 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 224 | 0.040 |
Why?
|
| Menopause | 1 | 2005 | 1646 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2020 | 326 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2720 | 0.040 |
Why?
|
| Urban Population | 2 | 2019 | 2036 | 0.040 |
Why?
|
| Fusobacterium | 1 | 2017 | 53 | 0.040 |
Why?
|
| Interleukins | 1 | 2002 | 782 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2014 | 18965 | 0.040 |
Why?
|
| Biological Oxygen Demand Analysis | 1 | 2016 | 5 | 0.040 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 201 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 2017 | 861 | 0.040 |
Why?
|
| Self Report | 2 | 2019 | 3725 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2017 | 1742 | 0.030 |
Why?
|
| Bacteroides | 1 | 2017 | 165 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 413 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6346 | 0.030 |
Why?
|
| Wettability | 1 | 2015 | 27 | 0.030 |
Why?
|
| Transfection | 2 | 2014 | 5774 | 0.030 |
Why?
|
| Denitrification | 1 | 2015 | 10 | 0.030 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1997 | 361 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 508 | 0.030 |
Why?
|
| Finland | 1 | 2017 | 607 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 5369 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2018 | 412 | 0.030 |
Why?
|
| Nuclear Family | 1 | 2016 | 311 | 0.030 |
Why?
|
| Microelectrodes | 1 | 2016 | 306 | 0.030 |
Why?
|
| Myocardium | 1 | 2008 | 4725 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2015 | 93 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2016 | 163 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 983 | 0.030 |
Why?
|
| Optical Phenomena | 1 | 2015 | 106 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 2319 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2015 | 165 | 0.030 |
Why?
|
| Bioreactors | 1 | 2016 | 247 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 17635 | 0.030 |
Why?
|
| Titanium | 1 | 2018 | 485 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2010 | 1218 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 748 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2017 | 392 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2020 | 881 | 0.030 |
Why?
|
| Soil | 1 | 2015 | 115 | 0.030 |
Why?
|
| Diffusion | 1 | 2016 | 814 | 0.030 |
Why?
|
| Humidity | 1 | 2015 | 205 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2017 | 12794 | 0.030 |
Why?
|
| Ligands | 2 | 2001 | 3272 | 0.030 |
Why?
|
| Arsenic | 1 | 2018 | 362 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2014 | 193 | 0.030 |
Why?
|
| Mifepristone | 1 | 2014 | 151 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1880 | 0.030 |
Why?
|
| Metagenome | 1 | 2017 | 450 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 364 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2015 | 296 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 6180 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2014 | 319 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 436 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 1161 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2000 | 711 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 522 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 841 | 0.030 |
Why?
|
| Rest | 1 | 2018 | 918 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2079 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 855 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 416 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 738 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2013 | 105 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1188 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 439 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 329 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 931 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2014 | 451 | 0.030 |
Why?
|
| Thalidomide | 1 | 2017 | 885 | 0.030 |
Why?
|
| Gastrectomy | 1 | 2017 | 672 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 254 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 1595 | 0.030 |
Why?
|
| Carbon | 1 | 2015 | 666 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 380 | 0.020 |
Why?
|
| Endometrium | 1 | 2014 | 403 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2011 | 30 | 0.020 |
Why?
|
| Body Temperature | 1 | 2015 | 781 | 0.020 |
Why?
|
| Propensity Score | 1 | 2019 | 1913 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 603 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 293 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Particle Size | 1 | 2015 | 1648 | 0.020 |
Why?
|
| Brazil | 1 | 2015 | 1230 | 0.020 |
Why?
|
| Liver | 2 | 2018 | 7529 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3839 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 293 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1596 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15601 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2012 | 238 | 0.020 |
Why?
|
| Spain | 1 | 2012 | 487 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 61 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2017 | 1440 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Food | 1 | 2015 | 774 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 264 | 0.020 |
Why?
|
| Cyprus | 1 | 2010 | 96 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2016 | 7967 | 0.020 |
Why?
|
| Urban Health | 1 | 2012 | 532 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2395 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2915 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 13446 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1186 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 899 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 322 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 270 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10766 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3603 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1341 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2015 | 852 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 1460 | 0.020 |
Why?
|
| Mental Recall | 1 | 2015 | 1221 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2014 | 1330 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 99 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1823 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 441 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 6019 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3597 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1745 | 0.020 |
Why?
|
| Apoptosis | 2 | 2015 | 9489 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5112 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2659 | 0.020 |
Why?
|
| Taq Polymerase | 1 | 2007 | 20 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2015 | 954 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1893 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4111 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6374 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1739 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2112 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3415 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 771 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2019 | 4471 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 2665 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2017 | 992 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5439 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 598 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 2009 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 1475 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3778 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2198 | 0.020 |
Why?
|
| Colon | 1 | 2014 | 1792 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 1250 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1769 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3639 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4124 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Zebrafish | 1 | 2016 | 3007 | 0.020 |
Why?
|
| Urinalysis | 1 | 2007 | 368 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 2638 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2416 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8181 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2803 | 0.010 |
Why?
|
| Guanine | 1 | 2005 | 279 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12341 | 0.010 |
Why?
|
| Vaccination | 1 | 2016 | 3384 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2015 | 2605 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4369 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1526 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3492 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4580 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2002 | 57 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2010 | 1387 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12441 | 0.010 |
Why?
|
| Caffeine | 1 | 2006 | 700 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2009 | 973 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2011 | 2856 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
| Brain | 1 | 2008 | 27120 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 5092 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.010 |
Why?
|
| Amphibian Proteins | 1 | 2001 | 36 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2020 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7593 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2011 | 2557 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8528 | 0.010 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 2001 | 332 | 0.010 |
Why?
|
| Peptide Hormones | 1 | 2001 | 132 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2009 | 2571 | 0.010 |
Why?
|
| Rural Population | 1 | 2010 | 2285 | 0.010 |
Why?
|
| Adenine | 1 | 2005 | 987 | 0.010 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2001 | 305 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 2000 | 184 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11121 | 0.010 |
Why?
|
| Models, Biological | 1 | 2015 | 9469 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2001 | 656 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 662 | 0.010 |
Why?
|
| Mitochondria | 1 | 2010 | 3624 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1463 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 10002 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11530 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 988 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 3076 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13642 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3792 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.010 |
Why?
|
| Peptides | 1 | 2001 | 4358 | 0.000 |
Why?
|
| Carcinoma | 1 | 2000 | 2330 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11076 | 0.000 |
Why?
|
| Rats | 1 | 2001 | 23741 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2000 | 4878 | 0.000 |
Why?
|